Normal view MARC view ISBD view

Examining Age and Postoperative Opioid Use in the Urogynecology Population: A Prospective Study.

MedStar author(s):

Citation: Urogynecology (Hagerstown, Md.). 28(12):872-878, 2022 Dec 01.PMID: 36409645Institution: MedStar Washington Hospital CenterDepartment: Obstetrics & Gynecology ResidencyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Analgesics, Opioid | *Opioid-Related Disorders | Adult | Aged | Analgesics, Opioid/tu [Therapeutic Use] | Female | Humans | Middle Aged | Opioid-Related Disorders/dt [Drug Therapy] | Pain, Postoperative/dt [Drug Therapy] | Practice Patterns, Physicians' | Prospective StudiesYear: 2022 ISSN:

2771-1897

Name of journal: Urogynecology (Hagerstown, Md.)Abstract: CONCLUSIONS: Younger women had higher postoperative opioid use despite similar pain scores after urogynecologic surgery. Among those prescribed opioids, a quarter of participants returned their opioids for disposal at their postoperative visit. Copyright © 2022 American Urogynecologic Society. All rights reserved.IMPORTANCE: Surgeons must individualize postoperative pain management while also reducing the amount of unused prescribed opioids.OBJECTIVES: This study compared postoperative opioid use in younger versus older women following urogynecologic surgery. We also assessed the likelihood of women returning unused opioids for safe disposal.RESULTS: From April 2019 to September 2021, 152 participants were enrolled: 92 (61%) in the younger cohort (mean age, 51 +/- 8 years) and 60 (39%) in the older cohort (mean age, 72 +/- 6 years). For our primary outcome, younger women used significantly more opioids during the first postoperative week compared with older women (49 +/- 71 vs 28 +/- 40 MME, respectively, P = 0.04), despite no difference in average pain scores (4 +/- 2 younger vs 3 +/- 2 older, P = 0.05). For our secondary outcome, 23% of participants returned their opioids for disposal with the drug deactivation system.STUDY DESIGN: This was a prospective study of women undergoing pelvic reconstructive surgery divided into 2 cohorts: younger (<65 years) and older (>=65 years). Our primary outcome was total opioid use, measured in morphine milligram equivalents (MME). We also assessed the average pain score during the first week after surgery measured by a numerical pain scale (range, 0-10). Our secondary outcome was the rate of return of unused prescribed opioids at the 6-week postoperative visit utilizing a disposable drug deactivation system.All authors: Chidgey BA, Connolly A, Dieter AA, Feliciano KM, Geller EJ, Leazer HA, Sun S, Willis-Gray MG, Wu JMFiscal year: FY2023 Digital Object Identifier:

https://dx.doi.org/10.1097/SPV.0000000000001251

Date added to catalog: 2022-12-13

Holdings ( 1 )
Title notes ( 6 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	36409645	Available		36409645

CONCLUSIONS: Younger women had higher postoperative opioid use despite similar pain scores after urogynecologic surgery. Among those prescribed opioids, a quarter of participants returned their opioids for disposal at their postoperative visit. Copyright © 2022 American Urogynecologic Society. All rights reserved.

IMPORTANCE: Surgeons must individualize postoperative pain management while also reducing the amount of unused prescribed opioids.

OBJECTIVES: This study compared postoperative opioid use in younger versus older women following urogynecologic surgery. We also assessed the likelihood of women returning unused opioids for safe disposal.

RESULTS: From April 2019 to September 2021, 152 participants were enrolled: 92 (61%) in the younger cohort (mean age, 51 +/- 8 years) and 60 (39%) in the older cohort (mean age, 72 +/- 6 years). For our primary outcome, younger women used significantly more opioids during the first postoperative week compared with older women (49 +/- 71 vs 28 +/- 40 MME, respectively, P = 0.04), despite no difference in average pain scores (4 +/- 2 younger vs 3 +/- 2 older, P = 0.05). For our secondary outcome, 23% of participants returned their opioids for disposal with the drug deactivation system.

STUDY DESIGN: This was a prospective study of women undergoing pelvic reconstructive surgery divided into 2 cohorts: younger (<65 years) and older (>=65 years). Our primary outcome was total opioid use, measured in morphine milligram equivalents (MME). We also assessed the average pain score during the first week after surgery measured by a numerical pain scale (range, 0-10). Our secondary outcome was the rate of return of unused prescribed opioids at the 6-week postoperative visit utilizing a disposable drug deactivation system.

English